Home > Riviste > Minerva Medica > Fascicoli precedenti > Articles online first > Minerva Medica 2021 Mar 08

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Medica 2021 Mar 08

DOI: 10.23736/S0026-4806.21.07281-5

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Epidemiology of severe asthma and international register

Elena TAGLIABUE , Elisa TRUCCO, Fulvio BRAIDO

Clinic of Respiratory Disease and Allergology, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy


PDF


Severe asthma (SA) in an asthma that requires therapy with high dose inhaled corticosteroids with a second controller, or oral corticosteroids, to ensure that it does not become ‘‘uncontrolled’’, or that it does not respond to appropriate therapy. Severe asthma has a great impact on quality of life. There is a great heterogeneity of this disease, not only from a clinical point of view, but also from a functional and pathophysiological one. It’s really hard to identify specific characteristics that identify this subgroup. Specific registers of SA, both national and international, are really important to describe the epidemiological characteristics of the disease and to analyze the clinical characteristics of the various subgroups of patients. This is an excellent starting point to be able to investigate the characteristics of the disease in detail.


KEY WORDS: Severe asthma; Severe asthma registry; Severe asthma epidemiology

inizio pagina